Fortress Biotech Sees Upgrades Amid Investor Shifts by Lilu Anderson 20.06.2024 "Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
FBIO Stock Soars: Fortress Biotech Beats Q4 Earnings by Mark Eisenberg 29.03.2024 Fortress Biotech's Q3 earnings per share of -53 cents exceeded the analyst estimate of -$1.97 while revenue of $19.95 million ...
Fortress Biotech Q4 Earnings Report: Analysts Predicted Loss by Mark Eisenberg 29.03.2024 Fortress Biotech Inc's shares dropped 27.9% this quarter, exceeding analysts' predicted loss of $1.97 per share.